Mar 31, 2026 TNX-4800: A Long-Acting, Borreliacidal (Bactericidal), Human Monoclonal Antibody to Prevent Lyme Disease in the U.S.
Sep 6, 2024 Using Synthetic Biology to Battle Mpox - Vaccine Symposium at the Department of Medical Microbiology & Immunology and the Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada
